Skip to main content
In stock|Cellular Therapy

Lifileucel

Oncology TypeSolid Tumour
Drug Class / MechanismAutologous Tumour-Infiltrating Lymphocyte (TIL) Therapy
No Image
Description

Lifileucel is classified as an Autologous Tumour-Infiltrating Lymphocyte (TIL) Therapy, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryCellular Therapy
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3